Af­ter a tough haul, John Lech­leit­er is step­ping down at Eli Lil­ly

Af­ter steer­ing Eli Lil­ly through a long R&D drought that leaves the phar­ma gi­ant with some block­buster drug prospects, Eli Lil­ly CEO John Lech­leit­er says it’s time to step aside.

Lech­leit­er said this morn­ing that he will step down from the helm at the end of this year, mak­ing way for pres­i­dent David Ricks to move up to the top spot. And af­ter a brief spell as ex­ec­u­tive chair­man, he will leave the com­pa­ny next spring.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.